FI73222B - Foerfarande foer framstaellning av nya makrolidantibiotika. - Google Patents

Foerfarande foer framstaellning av nya makrolidantibiotika. Download PDF

Info

Publication number
FI73222B
FI73222B FI833229A FI833229A FI73222B FI 73222 B FI73222 B FI 73222B FI 833229 A FI833229 A FI 833229A FI 833229 A FI833229 A FI 833229A FI 73222 B FI73222 B FI 73222B
Authority
FI
Finland
Prior art keywords
formula
desmycosin
ring
mmol
solution
Prior art date
Application number
FI833229A
Other languages
English (en)
Finnish (fi)
Other versions
FI833229A (fi
FI833229A0 (fi
FI73222C (sv
Inventor
Manuel Debono
Herbert Andrew Kirst
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI833229A0 publication Critical patent/FI833229A0/fi
Publication of FI833229A publication Critical patent/FI833229A/fi
Application granted granted Critical
Publication of FI73222B publication Critical patent/FI73222B/fi
Publication of FI73222C publication Critical patent/FI73222C/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Fodder In General (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Claims (6)

1. Förfarande för framställning av nya makrolid-antibiotica med formeln (I) 5 0 II /\ Il rH3
10 CH3 \ \ 19 20 i 6-CH2-CH2-R
03. CH, A r4_^ 3\ / \ (I)
2. J [ \
15 X0H [ AH CH, / 2'\ 3 0 >-N(CHJ, \-J-A CH3 l3 20 väri R är en monocyklisk mättad eller omättad ring som innehäller en kväveatom som enda heteroatom, varvid ringen bundits via kväveatomen och inkluderar 5-16 ringatomer, 25 eller en bicyklisk eller tricyklisk mättad eller omättad ring som innehäller en kväveatom som enda heteratom, varvid ringen bundits via kväveatomen och inkluderar 8-20 ringatomer, och den monocykliska, bicykliska eller tri-cykliska ringen är eventuellt substituerad i en eller 30 flera kloatomer med C^-C^-alkyl, fenyl, hydroxi, di-tC^-C^-alkyl)karbamoyl, piperidino, bensyl eller etylendioxi; 3 R är hydroxi eller 56 7 3 2 2 2 OH ·—i—ru -o / V 3 χ*-OH (mykarosyloxi) 5 CH, CH7 3 9H3 ! I i_0 eller j-o eller .*-0 io ho—y~°~ H0 —~~ H0_"y y*~° ~ ^3NOCH3 „/" \H H0 ^3 (mycinosyloxi) jämte syraadditionssalter därav, kännetecknat 15 därav, att man a) reducerar en aldehyd med formeln (III) 0 A_ ch3 20. ii l 3 0 CH3\ / \ V v V-ch^-ch I I 2 4 _/’ a3\/\ R 'CH2 i . I * OH 25 \ /*^OH ]_/ 11111 ch3 ° 4 \-n(ch3)2 / 3 CH3 r 3 4 30 väri R och R betecknar samma som i formeln (I), i närvaro av en amin med formeln HR, väri R betecknar samma som i formeln (I), eller b) omsätter en amin med formeln HR, väri R betecknar samma som i formeln (I), med en makrolid med formeln (IV), 35 57 73222 O II /\ 5 ί ί 3 C% X \ I NrCH2-CH2-L • /* CH A (IV) r4'cA . Y\ 1. c/2N°/[\/ XOH I _ A 1 r/ \ ch3 0^ ^.-N(CH3)2 / ~"\ r3 CH3 15 väri L är en avgäende grupp, vilken kan underträngas genora aminen HR, i ett icke-reaktivt organiskt lösningsmedel.
2. Förfarande enligt patentkravet 1 för framställ-ning av en makrolid med formeln (I),känneteck-n a t därav, att R är 20 (i) en mättad monocyklisk ring med formeln -N7^H2)n, väri n är ett heltal 4-15,varvid ringen eventuellt är substituerad i en eller flera kolatomer med C^-C^-alkyl, hydroxi, piperidino, di (C^-C^j-alkyl) karbamoyl eller (ii) en bicyklisk eller tricyklisk, sekundär amino-25 grupp som är 1.2.3.4- tetrahydrokinolin-l-yl, dekahydrokinolin-l-yl, 1.2.3.4- tetrahydroisokinolin-2-yl, dekahydroisokinolin-2-y1, 30 indolin-l-yl, isoindolin-2-yl, dekahydrocyklohepta£E>7pyrrol-1-yl, dekahydrocyklohepta/.q7pyrrol-2-yl, dekahydrocyklopent/c7azepin-2-yl, 35 dekahydrocyklopentZä7azepin-3-yl, 2.3.4.5- tetrahydro-lH-2-bensazepin-2-yl, 2.3.4.5- tetrahydro-lH-3-bensazepin-3-yl,
FI833229A 1982-09-13 1983-09-09 Förfarande för framställning av nya makrolidantibiotika. FI73222C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41724782A 1982-09-13 1982-09-13
US41724782 1982-09-13

Publications (4)

Publication Number Publication Date
FI833229A0 FI833229A0 (fi) 1983-09-09
FI833229A FI833229A (fi) 1984-03-14
FI73222B true FI73222B (fi) 1987-05-29
FI73222C FI73222C (sv) 1987-09-10

Family

ID=23653182

Family Applications (1)

Application Number Title Priority Date Filing Date
FI833229A FI73222C (sv) 1982-09-13 1983-09-09 Förfarande för framställning av nya makrolidantibiotika.

Country Status (34)

Country Link
EP (1) EP0103465B1 (sv)
JP (1) JPS5973598A (sv)
KR (1) KR850000961B1 (sv)
AR (1) AR241595A1 (sv)
AT (1) AT381707B (sv)
AU (1) AU561147B2 (sv)
BG (1) BG42675A3 (sv)
CA (1) CA1243310A (sv)
CS (1) CS259862B2 (sv)
CY (1) CY1417A (sv)
DD (1) DD210284A5 (sv)
DE (1) DE3366097D1 (sv)
DK (1) DK153555C (sv)
EG (1) EG16287A (sv)
ES (2) ES8604596A1 (sv)
FI (1) FI73222C (sv)
GB (1) GB2127017B (sv)
GR (1) GR79067B (sv)
HK (1) HK21888A (sv)
HU (1) HU194271B (sv)
IE (1) IE55916B1 (sv)
IL (1) IL69666A (sv)
LU (1) LU90240I2 (sv)
MY (1) MY8700756A (sv)
NL (1) NL950001I2 (sv)
NZ (1) NZ205501A (sv)
PH (1) PH23242A (sv)
PL (2) PL142304B1 (sv)
PT (1) PT77335B (sv)
RO (1) RO89235A (sv)
SG (1) SG99287G (sv)
SU (1) SU1375135A3 (sv)
UA (1) UA6045A1 (sv)
ZA (1) ZA836741B (sv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59181294A (ja) * 1983-03-30 1984-10-15 Satoshi Omura 抗生物質ptl−448とその誘導体およびそれらの製造方法
US4921947A (en) * 1986-03-31 1990-05-01 Eli Lilly And Company Process for preparing macrolide derivatives
US4820694A (en) * 1986-09-29 1989-04-11 Eli Lilly And Company Modifications of 3-O-demethylmycinose in macrocin and lactenocin
EP0262903A3 (en) * 1986-09-29 1988-11-02 Eli Lilly And Company New acyl derivatives of 20-modified tylosin and desmycosin compounds
US5354708A (en) * 1992-06-04 1994-10-11 Taskar Nikhil R Method of nitrogen doping of II-VI semiconductor compounds during epitaxial growth using an amine
TW226373B (sv) * 1992-07-15 1994-07-11 Pfizer
ES2076107B1 (es) * 1993-09-20 1996-04-01 Pfizer Derivados de antibioticos macrolidos de anillos de 16 miembros.
AU3121095A (en) * 1994-09-22 1996-04-09 Pfizer Inc. Antibiotic macrolides
EP0778283A3 (en) * 1995-12-05 1998-01-28 Pfizer Inc. Antibiotic macrolides
US6605599B1 (en) 1997-07-08 2003-08-12 Bristol-Myers Squibb Company Epothilone derivatives
DK0948967T3 (da) * 1998-03-02 2005-02-14 Lilly Co Eli Behandling af virussygdom hos svin
EP2019112A1 (en) 2007-07-26 2009-01-28 Intervet International BV Macrolide solid-state forms
US8227429B2 (en) 2006-07-28 2012-07-24 Intervet International B.V. Macrolide synthesis process and solid-state forms
EP2231635B1 (en) * 2007-12-07 2014-03-19 Eisai R&D Management Co., Ltd. Intermediates and methods for making zearalenone macrolide analogs
JP6494600B2 (ja) * 2013-05-23 2019-04-03 バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Animal Health Gmbh タイロシン誘導体およびその調製方法
CN103880903B (zh) * 2014-03-21 2016-06-15 烟台万润药业有限公司 一种泰乐菌素类大环内酯及其衍生物的制备方法
CN117510561B (zh) * 2023-11-30 2024-04-02 中国农业科学院饲料研究所 一种泰乐菌素衍生物及其制备方法与应用
CN117304241B (zh) * 2023-11-30 2024-03-01 中国农业科学院饲料研究所 一种大环内酯类化合物及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE32839B1 (en) * 1967-12-04 1973-12-28 Lilly Co Eli Urea-antibiotic adducts and process for preparing the same
US4279896A (en) * 1980-06-23 1981-07-21 Schering Corporation Novel 20-imino macrolide antibacterial agents
JPS58146595A (ja) * 1982-02-25 1983-09-01 Satoshi Omura マクロライド系抗生物質

Also Published As

Publication number Publication date
IE55916B1 (en) 1991-02-27
DK153555C (da) 1988-12-05
AT381707B (de) 1986-11-25
JPS5973598A (ja) 1984-04-25
IL69666A0 (en) 1983-12-30
JPH021840B2 (sv) 1990-01-12
IE832131L (en) 1984-03-13
ES8607336A1 (es) 1986-06-01
CS259862B2 (en) 1988-11-15
CS665383A2 (en) 1988-04-15
KR840005734A (ko) 1984-11-15
EP0103465B1 (en) 1986-09-10
DK413783D0 (da) 1983-09-12
ZA836741B (en) 1984-04-25
FI833229A (fi) 1984-03-14
PH23242A (en) 1989-06-06
PT77335B (en) 1986-05-19
IL69666A (en) 1987-10-20
ES525544A0 (es) 1986-02-01
DK153555B (da) 1988-07-25
GB8324044D0 (en) 1983-10-12
GR79067B (sv) 1984-10-02
SU1375135A3 (ru) 1988-02-15
MY8700756A (en) 1987-12-31
NZ205501A (en) 1985-09-13
BG42675A3 (en) 1988-01-15
AU1871083A (en) 1984-03-22
FI833229A0 (fi) 1983-09-09
DK413783A (da) 1984-03-14
PL142304B1 (en) 1987-10-31
PT77335A (en) 1983-10-01
DE3366097D1 (en) 1986-10-16
ATA320683A (de) 1986-04-15
DD210284A5 (de) 1984-06-06
GB2127017A (en) 1984-04-04
NL950001I1 (nl) 1995-02-16
PL250619A1 (en) 1985-07-30
LU90240I2 (fr) 1998-07-06
PL243718A1 (en) 1985-04-09
EG16287A (en) 1987-04-30
EP0103465A1 (en) 1984-03-21
HK21888A (en) 1988-03-31
ES8604596A1 (es) 1986-02-01
FI73222C (sv) 1987-09-10
UA6045A1 (uk) 1994-12-29
GB2127017B (en) 1986-01-15
NL950001I2 (nl) 1997-05-01
ES548472A0 (es) 1986-06-01
CA1243310A (en) 1988-10-18
AU561147B2 (en) 1987-04-30
CY1417A (en) 1988-04-22
KR850000961B1 (ko) 1985-07-02
HU194271B (en) 1988-01-28
PL142251B1 (en) 1987-10-31
HUT35272A (en) 1985-06-28
RO89235A (ro) 1986-03-15
AR241595A1 (es) 1992-09-30
SG99287G (en) 1988-09-23

Similar Documents

Publication Publication Date Title
FI73222B (fi) Foerfarande foer framstaellning av nya makrolidantibiotika.
US4820695A (en) C-20-dihydro-deoxy-(cyclic amino)-derivatives of macrolide antibiotics
RU2276135C2 (ru) Производные мутилинов и их применение в качестве антибактериальных средств
FI72322B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara marolider
EP0203621B1 (en) C-20-modified macrolide derivatives
GB2135670A (en) C-20- and c-23-modified macrolide derivatives
KR900008676B1 (ko) 항균성 9-데옥소-9a-알릴 및 프로파길-9a-아자-9a-호모에리트로마이신 A유도체
RU2220146C2 (ru) Новые производные ксантона, их получение и применение в качестве лекарственного средства
DD210060A5 (de) Verfahren zur herstellung von 5-0-mycaminosyltylonolidderivaten
JPS59167598A (ja) C−20−およびc−23−修飾マクロライド誘導体類
AT390733B (de) Verfahren zur behandlung oder unterdrueckung mikrobieller infektionen in einem warmbluetigen tier
DD210059A5 (de) Verfahren zur herstellung von in stellung c-23 modifizierten derivaten von dmt
KR19990044232A (ko) 트로바플록사신의 쯔비터이온 형태
US4604380A (en) C-23-substituted mycaminosyltylonolide compounds, pharmaceutical compositions and methods of use
JPS6341885B2 (sv)
BG60758B2 (bg) с-20-дихидро-дезокси-(циклени амино)-производни на макролидни антибиотици
SU731901A3 (ru) Способ получени олеандомицинов
KR790001501B1 (ko) 미데카마이신 유도체 제법
JPS6312066B2 (sv)

Legal Events

Date Code Title Description
MA Patent expired

Owner name: ELI LILLY AND COMPANY